For example, miR-100 suppressed ZBTB7A expression in gastric cancer [21], whereas miR-663a downregulated ZBTB7A expression in osteosarcoma [11], and MiR-372 inhibited ZBTB7A expression in oral carcinoma [23]. This evidence concerns the gene ZBTB7A and lip and oral cavity carcinoma.